Literature DB >> 34349234

Validity of the Urinary Symptom Questionnaires for people with neurogenic bladder (USQNB) who void or use indwelling catheters.

Rochelle E Tractenberg1,2,3, Jamie K Frost4, Futoshi Yumoto4, Amanda K Rounds5,6, Inger H Ljungberg5,6, Suzanne L Groah7,5.   

Abstract

STUDY
DESIGN: Descriptive Psychometrics Study
OBJECTIVES: Neurogenic lower urinary tract dysfunction (NLUTD), or "neurogenic bladder" is a common and disruptive condition for individuals with spinal cord injury (SCI) and disease (including multiple sclerosis, MS). Our team has developed patient-centered instruments of urinary symptoms specific to patients with NLUTD, across bladder management methods. Validity evidence is needed to support the use of two new instruments, Urinary Symptom Questionnaires for people with Neurogenic Bladder (USQNB) for those who manage their bladder with indwelling catheters (IDC), or who void (V).
SETTING: Online surveys completed by individuals in the United States with NLUTD due to either SCI or MS who manage their bladder with indwelling catheters (SCI, n = 306; MS, n = 8), or by voiding (SCI, n = 103; MS, n = 383). A total of n = 381 USQNB-IDC respondents (five control groups), and 351 USQNB-V respondents (four control groups), contributed to our convergent and divergent validity evidence.
METHODS: Data were collected online to estimate key aspects of psychometric validity (content, reflection of the construct to be measured; face, recognizability of the contents as representing the construct to be measured; structural, the extent to which the instrument captures recognizable dimensions of the construct to be measured). Divergent and convergent validity evidence was derived from multiple control groups, while evidence of criterion validity was derived from attribution of each item to their experience "with a UTI".
RESULTS: Evidence of face, content, criterion, convergent, and divergent validity was compiled for each instrument.
CONCLUSIONS: The instruments demonstrate adequate, multi-dimensional, validity evidence to recommend their use for decision-making by patients, clinicians, and researchers.
© 2021. The Author(s), under exclusive licence to International Spinal Cord Society.

Entities:  

Year:  2021        PMID: 34349234     DOI: 10.1038/s41393-021-00666-w

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  1 in total

1.  Preliminary validation of a Urinary Symptom Questionnaire for individuals with Neuropathic Bladder using Intermittent Catheterization (USQNB-IC): A patient-centered patient reported outcome.

Authors:  Rochelle E Tractenberg; Suzanne L Groah; Amanda K Rounds; Inger H Ljungberg; Manon M Schladen
Journal:  PLoS One       Date:  2018-07-10       Impact factor: 3.240

  1 in total
  3 in total

1.  Independence of Urinary Symptoms and Urinary Dipstick Results in Voiders With Neurogenic Bladder.

Authors:  Suzanne Groah; Rochelle E Tractenberg; Jamie K Frost; Amanda Rounds; Inger Ljungberg
Journal:  Top Spinal Cord Inj Rehabil       Date:  2022-02-25

2.  Establishing a core outcome set for neurogenic bladder trials: study protocol for a scoping review and Delphi surveys.

Authors:  Yan Zhang; Yamin Chen; Mingming Niu; Yuanyuan Li; Jiaoyan Zhang; Li Zhang; Fangfang Wu; Qingyun Chen; Huijin Yu; Jinhui Tian
Journal:  Trials       Date:  2022-06-13       Impact factor: 2.728

Review 3.  Catheter-Associated Urinary Tract Infections: Current Challenges and Future Prospects.

Authors:  Glenn T Werneburg
Journal:  Res Rep Urol       Date:  2022-04-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.